Case report: Coexistence of myotonia congenita and Brugada syndrome in one family

Myotonia congenita is a rare neuromuscular disorder caused by CLCN1 mutations resulting in delayed muscle relaxation. Extramuscular manifestations are not considered to be present in chloride skeletal channelopathies, although recently some cardiac manifestations have been described. We report a family with autosomal dominant myotonia congenita and Brugada syndrome. Bearing in mind the previously reported cases of cardiac arrhythmias in myotonia congenita patients, we discuss the possible involvement of the CLCN1-gene mutations in primary cardiac arrhythmia.

[1]  Nan Li,et al.  The Clinical, Myopathological, and Genetic Analysis of 20 Patients With Non-dystrophic Myotonia , 2022, Frontiers in Neurology.

[2]  Y. Péréon,et al.  Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study , 2021, Neuromuscular Disorders.

[3]  B. Schoser,et al.  Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patients , 2020, Journal of Neurology.

[4]  J. Brugada,et al.  Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic? , 2020, International journal of molecular sciences.

[5]  M. Hanna,et al.  Improving genetic diagnostics of skeletal muscle channelopathies , 2020, Expert review of molecular diagnostics.

[6]  M. Lo Monaco,et al.  Long-Term Safety and Usefulness of Mexiletine in a Large Cohort of Patients Affected by Non-dystrophic Myotonias , 2020, Frontiers in Neurology.

[7]  C. Pappone,et al.  Brugada Syndrome: Oligogenic or Mendelian Disease? , 2020, International journal of molecular sciences.

[8]  M. Pusch,et al.  An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies , 2020, Frontiers in Neurology.

[9]  G. Meola,et al.  Flecainide-Induced Brugada Syndrome in a Patient With Skeletal Muscle Sodium Channelopathy: A Case Report With Critical Therapeutical Implications and Review of the Literature , 2018, Front. Neurol..

[10]  V. Bissay,et al.  What the internist should know about hereditary muscle channelopathies , 2018, Acta clinica Belgica.

[11]  P. Brugada,et al.  SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies , 2015, European Journal of Human Genetics.

[12]  R. Mantegazza,et al.  ClC-1 chloride channels: state-of-the-art research and future challenges , 2015, Front. Cell. Neurosci..

[13]  J. Statland,et al.  Muscle Channelopathies: the Nondystrophic Myotonias and Periodic Paralyses , 2013, Continuum.

[14]  W. Catterall,et al.  Distribution and function of sodium channel subtypes in human atrial myocardium. , 2013, Journal of molecular and cellular cardiology.

[15]  L. Morandi,et al.  A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene , 2013, Journal of Human Genetics.

[16]  Tim T. Chen,et al.  Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy , 2013, Neurology.

[17]  D. Duan,et al.  Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart , 2009, The Journal of physiology.

[18]  J. Willer,et al.  Electromyography guides toward subgroups of mutations in muscle channelopathies , 2004, Annals of neurology.

[19]  G Lande,et al.  Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization , 2003, Neurology.

[20]  T. Jentsch,et al.  Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel , 1991, Nature.

[21]  Milne Anderson.  Probable thomsen's disease with cardiac involvement , 1977, Journal of Neurology.

[22]  P. J. Caballero.  Becker myotonia congenita associated with Wolff-Parkinson-White syndrome. , 2011, The neurologist.

[23]  S. Cannon,et al.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. , 2010, Brain : a journal of neurology.

[24]  G. Holmgren,et al.  Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia , 2001, European Journal of Human Genetics.